DK0854681T3 - Terapeutisk diæt til hunde med lymfom - Google Patents

Terapeutisk diæt til hunde med lymfom

Info

Publication number
DK0854681T3
DK0854681T3 DK96934026T DK96934026T DK0854681T3 DK 0854681 T3 DK0854681 T3 DK 0854681T3 DK 96934026 T DK96934026 T DK 96934026T DK 96934026 T DK96934026 T DK 96934026T DK 0854681 T3 DK0854681 T3 DK 0854681T3
Authority
DK
Denmark
Prior art keywords
omega
lymphoma
dogs
dry matter
fatty acids
Prior art date
Application number
DK96934026T
Other languages
Danish (da)
English (en)
Inventor
Gregory K Ogilvie
Deborah J Davenport
Kathy L Gross
Michael S Hand
Original Assignee
Colgate Palmolive Co
Gregory K Ogilvie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24172105&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0854681(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Colgate Palmolive Co, Gregory K Ogilvie filed Critical Colgate Palmolive Co
Application granted granted Critical
Publication of DK0854681T3 publication Critical patent/DK0854681T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/142Amino acids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/158Fatty acids; Fats; Products containing oils or fats
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/40Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/40Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A23K50/48Moist feed
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Husbandry (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Fodder In General (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Feed For Specific Animals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK96934026T 1995-10-10 1996-10-04 Terapeutisk diæt til hunde med lymfom DK0854681T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/544,421 US5776913A (en) 1995-10-10 1995-10-10 Therapeutic diet for metabolic abnormalities found in animals with lymphoma
PCT/US1996/015865 WO1997013415A1 (en) 1995-10-10 1996-10-04 Therapeutic diet for dogs with lymphoma

Publications (1)

Publication Number Publication Date
DK0854681T3 true DK0854681T3 (da) 2002-04-15

Family

ID=24172105

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96934026T DK0854681T3 (da) 1995-10-10 1996-10-04 Terapeutisk diæt til hunde med lymfom

Country Status (16)

Country Link
US (1) US5776913A (de)
EP (1) EP0854681B1 (de)
JP (1) JP4216334B2 (de)
AT (1) ATE210928T1 (de)
AU (1) AU707341B2 (de)
BR (1) BR9611044A (de)
CA (1) CA2234249C (de)
DE (1) DE69618218T2 (de)
DK (1) DK0854681T3 (de)
ES (1) ES2170269T3 (de)
MX (1) MXPA98002779A (de)
NO (1) NO325357B1 (de)
NZ (1) NZ319911A (de)
TR (1) TR199800744T2 (de)
WO (1) WO1997013415A1 (de)
ZA (1) ZA968482B (de)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6015798A (en) * 1995-10-10 2000-01-18 Colgate Palmolive Company Method for reducing the damaging effects of radiation therapy on animal skin and mucosa
US6077828A (en) * 1996-04-25 2000-06-20 Abbott Laboratories Method for the prevention and treatment of cachexia and anorexia
US5891925A (en) * 1997-06-27 1999-04-06 Abbott Laboratories Diagnostic method for assessing the serum cholesterol response to low diets
US6039952A (en) * 1997-10-22 2000-03-21 The Iams Company Composition and method for improving clinical signs in animals with renal disease
US6288116B1 (en) * 1998-05-13 2001-09-11 Novartis Nutrition Ag Method of administration of a nutritional product to a person having renal failure
AUPP887399A0 (en) * 1999-02-24 1999-03-25 Bartlett Grain Pty Ltd Animal feed formulae for the nutritional enrichment of foodstuffs
US6291496B1 (en) 1999-12-27 2001-09-18 Andrew J. Dannenberg Treating cancers associated with overexpression of class I family of receptor tyrosine kinases
US6436463B1 (en) 2000-06-26 2002-08-20 Hill's Pet Nutrition, Inc. Pet food composition and method
WO2002007531A1 (en) * 2000-07-14 2002-01-31 Societe Des Produits Nestle S.A. Dietary lipids for improving skin and coat of pets
US6506412B2 (en) * 2000-11-29 2003-01-14 Sciencebased Health Treatment of dry eye syndrome
US20030105104A1 (en) * 2001-11-27 2003-06-05 Burzynski Stanislaw R. Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy
US20030138547A1 (en) * 2002-01-22 2003-07-24 Mars, Incorporated Weight management system for animals
JP4600969B2 (ja) * 2002-01-22 2010-12-22 マース インコーポレーテッド 肥満動物のための体重管理システム
GB0207830D0 (en) * 2002-04-04 2002-05-15 Mars Uk Ltd Animal composition
US20040087490A1 (en) 2002-09-20 2004-05-06 Troup John P. Nutritional compositions
US8841344B2 (en) * 2002-10-03 2014-09-23 Hill's Pet Nutrition, Inc. Method of using omega-3 fatty acids
US6841179B2 (en) 2002-11-14 2005-01-11 The Meow Mix Company Pet food compositions comprising electrostatically charged gelatin
US6899904B2 (en) * 2002-11-14 2005-05-31 The Meow Mix Company Pet food compositions having electrostatically charged ingredient
AU2002368480A1 (en) * 2002-12-23 2004-07-14 Mars Uk Limited Food for gastrointestinal health
US8034372B2 (en) * 2003-03-05 2011-10-11 Nestec, Ltd. Dietary supplement for athletic pets
GB0311081D0 (en) * 2003-05-14 2003-06-18 Btg Internat Limted Treatment of neurodegenerative conditions
US8633247B2 (en) * 2003-08-11 2014-01-21 Hill's Pet Nutrition, Inc. Method for decreasing cartilage damage in dogs
US8633246B2 (en) * 2003-08-11 2014-01-21 Hill's Pet Nutrition, Inc. Omega-3 fatty acids for osteoarthritis
GB2422373B (en) 2003-08-18 2008-05-21 Btg Int Ltd Treatment of neurodegenerative conditions
ES2365617T3 (es) 2003-11-25 2011-10-07 Virginia Tech Intellectual Properties, Inc. Composición para su consumo en animales y método para reducir la actividad de map quinasa.
GB0425932D0 (en) * 2004-11-25 2004-12-29 Btg Int Ltd Structured phospholipids
US8431165B2 (en) * 2004-12-13 2013-04-30 Swing Aerobics Licensing, Inc. Medicament for treatment of cancer and other diseases
US8092839B2 (en) * 2004-12-13 2012-01-10 Swing Aerobics Licensing, Inc. Medicament for treatment of cancer and other diseases
JP5743373B2 (ja) * 2004-12-30 2015-07-01 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド ネコ食餌用の組成物
DK1838169T3 (en) * 2004-12-30 2016-08-15 Hills Pet Nutrition Inc Methods for improving the quality of life of a growing animal
CA2784197C (en) * 2004-12-30 2015-09-01 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
BRPI0519645A2 (pt) * 2004-12-30 2009-07-14 Hills Pet Nutrition Inc processo para preparar uma composição baseada em carne e carboidrato para consumo por um felino, produto, e, processo para preparar uma composição de ração para animal de estimação felino baseada em carne e carboidrato
GB0504333D0 (en) * 2005-03-02 2005-04-06 Btg Int Ltd Treatment of cytokine dysregulation
GB0504362D0 (en) * 2005-03-02 2005-04-06 Btg Int Ltd Cytokine modulators
WO2007002837A2 (en) * 2005-06-29 2007-01-04 Hill's Pet Nutrition, Inc. Methods and compositions for the prevention and treatement of inflammatory disease
ES2275435B1 (es) * 2005-11-18 2008-06-01 Farmaleis, S.L. "composicion farmaceutica que comprende escualeno y uso de la misma para la preparacion de un medicamento para el tratamiento del cancer.
JP5452501B2 (ja) * 2007-12-21 2014-03-26 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド ペット用飼料組成物
AU2013200758B2 (en) * 2008-07-18 2014-06-12 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
NO341929B1 (no) * 2009-09-14 2018-02-19 Chemoforma Ltd Fôrsammensetning
ES2882806T5 (en) 2011-02-02 2026-03-13 Nestle Sa High protein nutritional compositions and using same
EP3466418A1 (de) 2011-07-15 2019-04-10 NuSirt Sciences, Inc. Zusammensetzungen und verfahren zur modulierung von metabolischen signalwegen
SG11201503774PA (en) 2012-11-13 2015-06-29 Nusirt Sciences Inc Compositions and methods for increasing energy metabolism
CN105228627B (zh) 2013-03-15 2018-07-13 纽斯尔特科学公司 亮氨酸和烟酸降低脂质水平
US20160000737A1 (en) * 2013-03-15 2016-01-07 Nusirt Sciences, Inc. Treatment of pets with sirtuin activators
MX2016011063A (es) 2014-02-27 2016-11-30 Nusirt Sciences Inc Composiciones y metodos para la reduccion o prevencion de esteatosis hepatica.
CN113164420B (zh) * 2018-10-01 2025-01-03 温特穆特生物医学公司 治疗组合物
EP4022090B1 (de) * 2019-12-19 2026-03-18 Hill's Pet Nutrition, Inc. Zusammensetzungen in verfahren zur verminderung der gefahr des auftretens und zur behandlung von hypothyreose bei hunden
WO2021126221A1 (en) 2019-12-19 2021-06-24 Hill's Pet Nutrition, Inc. Compositions comprising a particular ratio of insoluble to soluble fibre for use in the treatment of e.g. anxiety
US20240081374A1 (en) 2022-09-14 2024-03-14 Société des Produits Nestlé S.A. Compositions and methods utilizing southern ocean mackerel oil for providing health benefits in an animal

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4282254A (en) * 1979-10-04 1981-08-04 General Foods Corporation Dog food of improved acceptability
JP2723243B2 (ja) * 1988-02-25 1998-03-09 サントリー株式会社 高度不飽和脂肪酸添加動物飼料
US5780039A (en) * 1992-04-23 1998-07-14 Novartis Nutrition Ag Orally-ingestible nutrition compositions having improved palatability
JPH0638708A (ja) * 1992-05-15 1994-02-15 Earth Chem Corp Ltd ナトリウム吸収阻害剤、ナトリウム吸収阻害剤を含有する高血圧予防食品、及び高血圧治療剤
JP3347381B2 (ja) * 1993-01-27 2002-11-20 協和醗酵工業株式会社 ペットフード
CA2147109A1 (en) * 1994-04-18 1995-10-19 Gregory A. Reinhart Pet food product containing omega-6 and omega-3 fatty acids and process for reducing inflammatory skin responses

Also Published As

Publication number Publication date
ES2170269T3 (es) 2002-08-01
NO981593L (no) 1998-06-09
NZ319911A (en) 1998-12-23
WO1997013415A1 (en) 1997-04-17
EP0854681B1 (de) 2001-12-19
AU7254596A (en) 1997-04-30
CA2234249C (en) 2002-03-26
NO325357B1 (no) 2008-04-07
DE69618218T2 (de) 2002-08-22
US5776913A (en) 1998-07-07
NO981593D0 (no) 1998-04-07
DE69618218D1 (de) 2002-01-31
BR9611044A (pt) 1999-12-28
ZA968482B (en) 1998-04-08
EP0854681A1 (de) 1998-07-29
CA2234249A1 (en) 1997-04-17
TR199800744T2 (xx) 1998-08-21
ATE210928T1 (de) 2002-01-15
JPH11513561A (ja) 1999-11-24
JP4216334B2 (ja) 2009-01-28
MXPA98002779A (es) 2003-08-08
AU707341B2 (en) 1999-07-08

Similar Documents

Publication Publication Date Title
NO981593D0 (no) Terapeutisk diett for hunder med lymfoma
Christie The effects of diet and other factors on the lipid composition of ruminant tissues and milk
EP1392127B1 (de) Verfahren zur verbesserung des geschmacks, der zartheit und der verbraucherakzeptanz insgesamt von geflügelfleisch
Hulan et al. Omega-3 fatty acid levels and general performance of commercial broilers fed practical levels of redfish meal
Mansbridge et al. Nutritional factors affecting the fatty acid composition of bovine milk
EP0440308B1 (de) Pharmazeutische und diätetische Zusammensetzung
NZ510932A (en) Animal feed additive composition comprising at least two antimicrobial enzymes and one or more PUFAs for feeding to pigs, poultry, veal calves and fish
EP0651611A4 (en) Modified fat blends.
Choi et al. Accumulation of conjugated linoleic acid (CLA) in tissues of fish fed diets containing various levels of CLA
Jenkins Feeding oleamide to lactating Jersey cows 1. Effects on lactation performance and milk fatty acid composition
Kennedy et al. Influence of dietary conjugated linoleic acid (CLA) on lipid and fatty acid composition in liver and flesh of Atlantic salmon (Salmo salar)
DK1753302T3 (da) Sammensætning til dyrefoder og fremgangsmåde til at reducere map-kinaseaktivitet
Ahrens et al. Utilization of calories and nitrogen by rats fed diets containing purified casein versus a mixture of amino acids simulating casein
Barlow Effects of diet on the composition of body fat in Agria affinis (Fallén)
Sim et al. Effect of dietary oil, cholesterol, and soysterols on the lipid concentration and fatty acid composition of egg yolk, liver and serum of laying hens
JPS5780377A (en) Ruminant animal feed improving additive
US4764532A (en) Treatment of horses
Witter et al. The influence of the amount and nature of dietary fat on milk fat composition in the sow
Bieri et al. Linoleic acid requirement of the chick
Sang-Min et al. Effect of dietary Sargassum meal on growth and body composition of ayu (Plecoglossus altivelis) reared in seawater
JPH035784B2 (de)
Baustad Cottonseed meal in the feeding of growing pigs
Herting et al. Absorption of vitamin E by the rat from a low fat diet
Husveth et al. N-3 fatty acid enrichment of table eggs by adding a fish oil preparation (Nordos Fat®) to the diet of laying hens
Or-Rashid et al. Supplemental algal-meal alters the ruminal trans-18: 1 fatty acid and CLA 3 composition in cattle